Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast cancer. Here, we comprehensively profiled 817 breast tumors, including 127 ILC, 490 ductal (IDC), and 88 mixed IDC/ILC. Besides E-cadherin loss, the best known ILC genetic hallmark, we identified mutations targeting PTEN, TBX3 and FOXA1 as ILC enriched features. PTEN loss associated with increased AKT phosphorylation, which was highest in ILC among all breast cancer subtypes. Spatially clustered FOXA1 mutations correlated with increased FOXA1 expression and activity. Conversely, GATA3 mutations and high expression characterized Luminal A IDC, suggesting differential modulation of ER activity in ILC and IDC. Proliferation and immune-related si...
Accounting for 10-15% of all breast neoplasms, invasive lobular breast cancer (ILC) is the second mo...
Invasive lobular carcinoma (ILC) is the most common special type of breast cancer, and is characteri...
Invasive lobular breast cancer (ILC) is an understudied malignancy with distinct clinical, pathologi...
Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast ...
SummaryInvasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive ...
Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast ...
Invasive lobular carcinoma (ILC) is the second most frequently occurring histological breast cancer ...
Invasive lobular carcinoma (ILC) is the second most frequently occurring histological breast cancer ...
Invasive lobular carcinoma (ILC) accounts for up to 15% of all invasive breast cancers. We have long...
International audiencePurpose Invasive lobular breast cancer (ILBC) is the second most common histol...
PURPOSE: Invasive lobular breast cancer (ILBC) is the second most common histologic subtype after in...
International audienceInvasive ductal carcinomas (IDCs) and invasive lobular carcinomas (ILCs) are t...
International audiencePurpose: Invasive lobular carcinoma (ILC) represents the second most common hi...
© 2021 Medha SumanInvasive lobular breast cancer (ILBC) is the second most common histological subty...
PURPOSE: Invasive lobular carcinoma (ILC) represents the second most common histologic breast cancer...
Accounting for 10-15% of all breast neoplasms, invasive lobular breast cancer (ILC) is the second mo...
Invasive lobular carcinoma (ILC) is the most common special type of breast cancer, and is characteri...
Invasive lobular breast cancer (ILC) is an understudied malignancy with distinct clinical, pathologi...
Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast ...
SummaryInvasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive ...
Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast ...
Invasive lobular carcinoma (ILC) is the second most frequently occurring histological breast cancer ...
Invasive lobular carcinoma (ILC) is the second most frequently occurring histological breast cancer ...
Invasive lobular carcinoma (ILC) accounts for up to 15% of all invasive breast cancers. We have long...
International audiencePurpose Invasive lobular breast cancer (ILBC) is the second most common histol...
PURPOSE: Invasive lobular breast cancer (ILBC) is the second most common histologic subtype after in...
International audienceInvasive ductal carcinomas (IDCs) and invasive lobular carcinomas (ILCs) are t...
International audiencePurpose: Invasive lobular carcinoma (ILC) represents the second most common hi...
© 2021 Medha SumanInvasive lobular breast cancer (ILBC) is the second most common histological subty...
PURPOSE: Invasive lobular carcinoma (ILC) represents the second most common histologic breast cancer...
Accounting for 10-15% of all breast neoplasms, invasive lobular breast cancer (ILC) is the second mo...
Invasive lobular carcinoma (ILC) is the most common special type of breast cancer, and is characteri...
Invasive lobular breast cancer (ILC) is an understudied malignancy with distinct clinical, pathologi...